TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15236012

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intramuscular pethidine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 34
Study: 6990334

Group type: EXPERIMENTAL
Intervention: Early treatment with antimicrobials (cefamandole) starting preoperatively and continuing for 4 days
Number of subjects: 337

Group type: COMPARATOR
Intervention: Standard treatment (treatment only if infection was apparent)
Number of subjects: 337
Study: 31091248

Group type: EXPERIMENTAL
Intervention: Ingroup‐slanted inflow of information
Number of subjects: 0
Study: 28257735

Group type: EXPERIMENTAL
Intervention: Medium intermaxillary elastics
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Heavy intermaxillary elastics
Number of subjects: 52

Group type: COMPARATOR
Intervention: All elastics
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Heavy elastics
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Medium elastics
Number of subjects: 52
Study: 26083700

Group type: EXPERIMENTAL
Intervention: Alpine skiing intervention for 12 weeks
Number of subjects: 0
Study: 23728174

Group type: EXPERIMENTAL
Intervention: Exenatide (subcutaneous injection for 12 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 45
Study: 19663929

Group type: EXPERIMENTAL
Intervention: Altitude of 3500 m and higher
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Increasing altitude
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Altitude (all levels)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Altitude (3500 m and higher)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Altitude
Number of subjects: 19
Study: 18617745

Group type: EXPERIMENTAL
Intervention: Osteopathic intervention (45 min every other week)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sham ultrasound (12 min once a week for 10 weeks)
Number of subjects: 41
Study: 12788888

Group type: EXPERIMENTAL
Intervention: 1 implant of MENT (400 microg/d x implant)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2 implants of MENT (400 microg/d x implant)
Number of subjects: 16
Study: 10825322

Group type: EXPERIMENTAL
Intervention: Fentanyl infusion at 1.5 ng/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl infusion at 3.0 ng/mL
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl infusion at 4.5 ng/mL
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Postoperative IV patient-controlled analgesia fentanyl
Number of subjects: 60
Study: 8996955

Group type: EXPERIMENTAL
Intervention: Education group (individual education programme lasting at least one hour)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 1737255

Group type: EXPERIMENTAL
Intervention: Disodium pamidronate
Number of subjects: 0
Study: 6363158

Group type: EXPERIMENTAL
Intervention: Diproderm cream 0.05%, applied twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diproderm cream 0.05%, applied once a day
Number of subjects: 0
Study: 30597580

Group type: EXPERIMENTAL
Intervention: Audio Tactile Performance (ATP) technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Braille and audio aids (Control)
Number of subjects: 0
Study: 29975723

Group type: EXPERIMENTAL
Intervention: Intervention video (basic response to a hospital fire)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control video (introduction to volcanic disasters)
Number of subjects: 128
Study: 27015260

Group type: EXPERIMENTAL
Intervention: Self-sampling for HPV and results counseling
Number of subjects: 94

Group type: COMPARATOR
Intervention: Information-only group
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Self-sampling for HPV
Number of subjects: 94
Study: 24629400

Group type: EXPERIMENTAL
Intervention: Central systolic blood pressure (SBP)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Central diastolic blood pressure (DBP)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Central pulse pressure variability
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Central augmented pressure
Number of subjects: 57
Study: 22795613

Group type: COMPARATOR
Intervention: IV morphine alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IV morphine and IV oxycodone (0.75 mg each)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IV morphine plus IV oxycodone (0.5 mg/0.5 mg) via PCA
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1 mg IV morphine alone via PCA
Number of subjects: 40
Study: 20542087

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) representation in a ReaCTor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2D computer screen (conventional neurofeedback medium)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-training comparison group
Number of subjects: 0
Study: 18090745

Group type: EXPERIMENTAL
Intervention: Systematic reviews
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled clinical trials
Number of subjects: 0
Study: 17519714

Group type: EXPERIMENTAL
Intervention: 2.5 ml 0.75% ropivacaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2.5 ml 2% lidocaine
Number of subjects: 70
Study: 15009349

Group type: EXPERIMENTAL
Intervention: Training for MCHN in identification and management of distressed mothers, including access to a liaison psychiatric network for consultation and referrals.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard management services provided by control group nurses.
Number of subjects: 40
Study: 10971240

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lansoprazole 7.5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Omeprazole 10 mg
Number of subjects: 12
Study: 9083904

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate mouthwash
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 8451009

Group type: EXPERIMENTAL
Intervention: Aspartame 600 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Aspartame 1200 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3082175

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tocainide
Number of subjects: 29
Study: 31317843

Group type: EXPERIMENTAL
Intervention: Radically Open Dialectical Behaviour Therapy (RO DBT) plus Treatment as Usual (TAU)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Radically Open Dialectical Behaviour Therapy (RO DBT)
Number of subjects: 250
Study: 31127381

Group type: COMPARATOR
Intervention: Aflibercept injections alone (Group A)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Aflibercept injections followed by micropulsed laser (Group B)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 51
Study: 27566242

Group type: EXPERIMENTAL
Intervention: Bone marrow aspirate concentrate (BMAC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 25
Study: 25817883

Group type: EXPERIMENTAL
Intervention: Immediate loading (final prosthesis delivered within 24 hours)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Delayed loading
Number of subjects: 15
Study: 24706354

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral conjoint therapy for PTSD
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 40
Study: 21823174

Group type: EXPERIMENTAL
Intervention: Group music intervention using percussion instruments with familiar music, 30-min sessions, twice weekly for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care with no music intervention
Number of subjects: 60
Study: 19326141

Group type: EXPERIMENTAL
Intervention: HYPOXIC (F(I)O(2) = 0.15)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CONTROL (F(I)O(2) = 0.21)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HYPOXIC
Number of subjects: 0
Study: 17364111

Group type: EXPERIMENTAL
Intervention: OAS (dual-site atrial pacing with the specific pacing algorithm turned on)
Number of subjects: 25
Study: 15366327

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate prolonged-release tablet formulation (60 mg)
Number of subjects: 24
Study: 11443470

Group type: EXPERIMENTAL
Intervention: Continuous propofol administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane administration
Number of subjects: 40
Study: 10186520

Group type: EXPERIMENTAL
Intervention: Recently developed analysing method
Number of subjects: 0
Study: 8067564

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg/kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3386500

Group type: EXPERIMENTAL
Intervention: NaHCO3 (alkalosis)
Number of subjects: 6
Study: 30999884

Group type: EXPERIMENTAL
Intervention: Patient navigator intervention for 24 weeks
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care (waitlisted control) until receipt of patient navigator at 24 weeks
Number of subjects: 210
Study: 29102016

Group type: EXPERIMENTAL
Intervention: Cigar Box Arthroscopy Trainer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anatomic Knee Arthroscopy Trainer (AKAT)
Number of subjects: 0
Study: 25968007

Group type: EXPERIMENTAL
Intervention: Blue-blocking intraocular lenses (IOLs)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Clear intraocular lenses (IOLs)
Number of subjects: 1000
Study: 23920422

Group type: EXPERIMENTAL
Intervention: MK-0249 (5, 8, 10, or 12 mg)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: MK-0249
Number of subjects: 125
Study: 21995156

Group type: EXPERIMENTAL
Intervention: Topical lipohydroperoxides and glycyrrhetic acid for three days (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vaginal antibacterial metronidazole (500 mg) or antimycotic econazole (150 mg) for six days (n = 50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Topical lipohydroperoxides and glycyrrhetic acid
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vaginal antibacterial metronidazole or antimycotic econazole
Number of subjects: 100
Study: 19337019

Group type: EXPERIMENTAL
Intervention: Insulin glargine (IG) + repaglinide
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Insulin glargine (IG) + acarbose
Number of subjects: 38
Study: 16924016

Group type: EXPERIMENTAL
Intervention: Temporal lobe epilepsy surgery (amygdalo-hippocampectomy and neocortical temporal resection between 2.5 and 8 cm)
Number of subjects: 85
Study: 14999200

Group type: EXPERIMENTAL
Intervention: losartan (50 mg/d)
Number of subjects: 225

Group type: COMPARATOR
Intervention: captopril (50 mg 3 times/d)
Number of subjects: 225
Study: 15592193

Group type: EXPERIMENTAL
Intervention: Gated SPECT imaging soon after exercise
Number of subjects: 52
Study: 10705305

Group type: EXPERIMENTAL
Intervention: r‐IL‐2 therapy (12 M IU/m2/day continuous infusion on day 1‐5, 15‐17, 29‐31, 43‐45 and 57‐59)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no r‐IL‐2 therapy)
Number of subjects: 130
Study: 9158540

Group type: EXPERIMENTAL
Intervention: Frequent quizzes administered at the beginning of each class (Quiz Group - QG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No quizzes (Control Group - CG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequent quizzes (QG)
Number of subjects: 0
Study: 1540458

Group type: EXPERIMENTAL
Intervention: Lignocaine spray
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Three cotton swabs soaked in 4% lignocaine solution
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 2% lignocaine gel
Number of subjects: 31
Study: 3954967

Group type: EXPERIMENTAL
Intervention: Leucocyte-poor blood components
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard (non-leucocyte-depleted) blood components
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leucocyte-poor blood components and HLA-matched platelets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 29540090

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME/Kegel) training, 3 times a day for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: No exercises (Control group)
Number of subjects: 60
Study: 27802078

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted vaccine
Number of subjects: 179
Study: 25451347

Group type: EXPERIMENTAL
Intervention: Arformoterol (15 μg bid)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Arformoterol
Number of subjects: 841
Study: 22342501

Group type: EXPERIMENTAL
Intervention: Intanza(®) 15 μg intradermal vaccine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intramuscular (IM) Vaxigrip(®) vaccine
Number of subjects: 50
Study: 20516155

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy
Number of subjects: 221

Group type: COMPARATOR
Intervention: Supportive therapy
Number of subjects: 221
Study: 18541078

Group type: EXPERIMENTAL
Intervention: Dexamethasone (2 ml) plus ondansetron 4 mg (2 ml)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg (2 ml) and normal saline (2 ml)
Number of subjects: 100
Study: 16183940

Group type: EXPERIMENTAL
Intervention: Indeterminate CT pulmonary angiograms
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (diagnostic studies)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Follow-up imaging
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Treatment for thromboembolic disease
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Recommendations for follow-up imaging
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Clinical interpretation of studies
Number of subjects: 237
Study: 14569216

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatments for sciatica
Number of subjects: 31
Study: 10342001

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 62

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 62
Study: 8565536

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (2 g, 8 mmol)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (5% dextrose in water)
Number of subjects: 32
Study: 1759835

Group type: EXPERIMENTAL
Intervention: Org 10172 (intravenous bolus injection of 3,250 anti‐Xa units) + cloxacillin (500 mg orally four times daily for 3 days)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Org 10172 (intravenous bolus injection of 3,250 anti‐Xa units) + ticarcillin (4,000 mg intravenously four times daily for 2 days)
Number of subjects: 18
Study: 7058755

Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone (800 mg/day)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone
Number of subjects: 182
Study: 29987345

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrocolpopexy/cervicopexy (LSC‐Cx)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Anterior vaginal mesh (AVM)
Number of subjects: 120
Study: 28316023

Group type: EXPERIMENTAL
Intervention: Transconjunctival approach
Number of subjects: 40

Group type: COMPARATOR
Intervention: Subciliary approach
Number of subjects: 40
Study: 25681237

Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3
Number of subjects: 119

Group type: COMPARATOR
Intervention: 50,000 IU vitamin D3
Number of subjects: 119
Study: 23339040

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Historical group
Number of subjects: 116
Study: 21303190

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (twice weekly for 3 weeks, total six sessions)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Observation (routine care with weekly visits)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 90
Study: 19843340

Group type: EXPERIMENTAL
Intervention: Focused structural massage
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Relaxation massage
Number of subjects: 399

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 399
Study: 17251882

Group type: EXPERIMENTAL
Intervention: Calfactant via endotracheal tube
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 15082488

Group type: EXPERIMENTAL
Intervention: Multidisciplinary vocational rehabilitation programme
Number of subjects: 65
Study: 11942472

Group type: EXPERIMENTAL
Intervention: Increase in plasma malondialdehyde (SD = 0.11 microM)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Increase in plasma 8-iso-prostaglandin F2alpha (SD = 8.88 ng/L)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Increase in apolipoprotein B (SD = 0.27 g/L)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Increase in proportion of stearic acid (18:0) in serum cholesterol esters (SD = 0.12 percent units)
Number of subjects: 58
Study: 9849473

Group type: EXPERIMENTAL
Intervention: QUART (quadrantectomy, axillary dissection and radiotherapy)
Number of subjects: 705

Group type: COMPARATOR
Intervention: TART (tumorectomy and axillary dissection followed by external radiotherapy and a boost with 192Ir implantation)
Number of subjects: 705
Study: 7584295

Group type: EXPERIMENTAL
Intervention: Low-frequency words
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-frequency words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recollection-based processes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiarity-based processes
Number of subjects: 0
Study: 2679288

Group type: EXPERIMENTAL
Intervention: Sequential methotrexate and fluorouracil (M-F) followed by leucovorin in Protocol B-13
Number of subjects: 3865

Group type: EXPERIMENTAL
Intervention: Tamoxifen (10 mg twice daily) in Protocol B-14
Number of subjects: 3865

Group type: COMPARATOR
Intervention: Placebo in Protocol B-14
Number of subjects: 3865
Study: 785426

Group type: EXPERIMENTAL
Intervention: Aerosol vaccine
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Whole-virion vaccine
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Tween-ether ‘split’ vaccine
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Aerosol vaccine (field trial)
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Whole-virion vaccine (field trial)
Number of subjects: 601
Study: 6988032

Group type: EXPERIMENTAL
Intervention: Radical mastectomy (RM)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Simple mastectomy and postoperative radiotherapy (SM)
Number of subjects: 498
Study: 28670906

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet intervention
Number of subjects: 36
Study: 29411724

Group type: EXPERIMENTAL
Intervention: LACB-7 (7-day quadruple therapy)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: LACB-14 (14-day quadruple therapy)
Number of subjects: 70
Study: 26367239

Group type: EXPERIMENTAL
Intervention: Third-line chemotherapy
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Transplantation (ASCT or allogeneic SCT)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 203

Group type: COMPARATOR
Intervention: International Prognostic Index (IPI) at relapse
Number of subjects: 203

Group type: COMPARATOR
Intervention: Transplantation
Number of subjects: 203
Study: 24799480

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 204

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 204
Study: 22506795

Group type: EXPERIMENTAL
Intervention: Teleconferencing supervision (TCS; n = 32)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard tape-based supervision (tape; n = 32)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Workshop alone (workshop; n = 33)
Number of subjects: 97
Study: 20846715

Group type: EXPERIMENTAL
Intervention: Thalidomide 200mg daily (escalated to 400mg)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Tamoxifen 20mg orally twice daily
Number of subjects: 138
Study: 17641533

Group type: EXPERIMENTAL
Intervention: 35 mg cortisol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 12607856

Group type: EXPERIMENTAL
Intervention: System One (chemically cured composite resin)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Light Bond (light‐cured composite resin)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC (light‐cured glass ionomer cement) with acid-etching
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC (light‐cured glass ionomer cement) without acid-etching
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vivaglass Cem (self‐curing glass ionomer cement)
Number of subjects: 50
Study: 10709791

Group type: EXPERIMENTAL
Intervention: Community-wide interventions including direct action community organizing, youth development, print media, parent education, and classroom-based curriculum.
Number of subjects: 24
Study: 9176721

Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoprenaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol after Adrenaline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 7584010

Group type: EXPERIMENTAL
Intervention: Neurotrauma management principles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multicenter clinical pharmacologic trials
Number of subjects: 0